NEW YORK (GenomeWeb News) – Diagnostic firm Theradiag today announced a partnership with French organizations to develop diagnostic and theranostic tools for rheumatoid arthritis.

The agreement between Theradiag, the French National Center for Scientific Research/The Institute of Molecular Genetics of Montpellier, and the Universities of Montpellier 1 and 2 is focused on identifying microRNA signatures to improve the ability of tests to diagnose RA, to analyze disease activity and severity of the disease, and to predict response to therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.